SCHEMBL19909196

SCHEMBL19909196

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)cc(-n2c3ccc(C)cc3c3cc(C)ccc32)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.46
KDM4E B2RXH2 5/20 0.46
ADORA2A P29274 4/20 0.46
NPSR1 Q6W5P4 3/20 0.46
HPGD P15428 2/20 0.46
PPARG P37231 1/20 0.46
NCOA2 Q15596 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
ALDH1A1 P00352 5/20 0.42
SQOR Q9Y6N5 3/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 1/20 0.40
RECQL P46063 1/20 0.40
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273577 0.99 ADORA1 (0.45) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL19909133 0.96 KDM4E (0.44) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL22170312 0.95 ADORA1 (0.43) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL19909220 0.92 ADORA1 (0.49) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL22563698 0.92 KDM4E (0.45) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL22562362 0.92 ADORA1 (0.44) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL19913308 0.91 ADORA2A (0.50) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL21278715 0.91 ADORA1 (0.44) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL19909224 0.90 ADORA1 (0.44) ADORA1KDM4EADORA2ANPSR1HPGD
SCHEMBL19913309 0.89 ADORA2A (0.45) ADORA1KDM4EADORA2ANPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ADORA1 3690/4885KDM4E 4364/4885ADORA2A 1368/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ADORA1 3690/4885KDM4E 4364/4885ADORA2A 1368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.